ifosfamide has been researched along with Head and Neck Neoplasms in 60 studies
Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ifosfamide has shown significant activity as a single agent in head and neck squamous carcinoma." | 5.10 | Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: a retrospective analysis of 519 patients: a single institution experience. ( Bakshi, AV; Deshmukh, CD; Mazumdar, AT; Mistry, RC; Pai, VR; Parikh, DM; Parikh, PM; Pathak, KA, 2003) |
| "Thirty-six patients with recurrent carcinoma of the head and neck and no prior exposure to chemotherapy were treated with Ifosfamide." | 5.07 | Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer. ( Barón, FJ; Buesa, JM; Esteban, E; Estrada, E; Fernández, R; Gracia, M; Lacave, AJ; Palacio, I, 1991) |
| " Hence, we decided to explore the option of neoadjuvant chemotherapy using effective agents like ifosfamide and paclitaxel in combination with cisplatin in these patients." | 2.71 | Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patients. ( Bakshi, AV; D'Cruz, AK; Deshmukh, CD; Mazumdar, AT; Mistry, RC; Pai, VR; Parikh, DM; Parikh, PM; Pathak, KA, 2004) |
| "Ifosfamide was given initially to 12 patients in combination with standard fixed doses of cisplatin and 5-fluorouracil, at 1,000 mg/m2 daily on days 2, 3, and 4." | 2.69 | Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma. ( Abad, T; Alvárez, I; Churruca, C; Egana, L; Guimón, E; Lacasta, A; López de Argumedo, G; Paredes, A; Piera, JM; Sánchez Parra, M, 1999) |
| " A doubling of the intensity of cyclophosphamide (or ifosfamide equivalent) dosing per cycle between IRS-III and IRS-IV is thought to be a key contributing factor for this improvement." | 2.69 | Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. ( Anderson, JR; Baker, KS; Breneman, JC; Crist, WM; Grier, HE; Link, MP; Maurer, HM; Qualman, SJ; Wiener, ES, 2000) |
| "Granulocytopenia was the dose-limiting toxicity." | 2.68 | Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck. ( Benner, SE; Hong, WK; Huber, MH; Lippman, SM, 1995) |
| "Ifosfamide is an active agent in recurrent squamous cell carcinoma of the head and neck." | 2.68 | A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck. ( Benner, SE; Dimery, IW; Dunnington, JS; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M, 1996) |
| "A total of 37 men with epidermoid head and neck cancer whose disease had recurred following primary treatment (surgery and/or radiotherapy) received first-line chemotherapy with ifosfamide at i." | 2.67 | Ifosfamide in advanced epidermoid head and neck cancer. ( Almenarez, J; Casado, A; Diaz-Rubio, E; Dominguez, S; González Larriba, JL; López-Vega, JM; Martín, M; Sastre, J, 1993) |
| "Ifosfamide (IFO) has demonstrated activity in recurrent/metastatic squamous cell head and neck carcinoma with an overall response rate of 24-26%." | 2.42 | Ifosfamide in the treatment of head and neck cancer. ( Airoldi, M; Bumma, C; Cortesina, G; Giordano, C; Pedani, F, 2003) |
| "Patients with advanced squamous cell head and neck cancer have a dismal long-term survival rate not only because of metastatic disease, but also primarily because of failure in local disease control." | 2.41 | Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. ( Glisson, BS; Hong, WK; Khuri, FR; Lippman, SM; Shin, DM, 2000) |
| " The Eastern Cooperative Oncology Group is currently evaluating high-dose (200 mg/m2) and low-dose (135 mg/m2) paclitaxel in combination with cisplatin to assess dose-response effects, toxicity, and efficacy." | 2.39 | Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer. ( Forastiere, AA; Urba, SG, 1995) |
| "Myxofibrosarcoma is an aggressive soft tissue neoplasm, classified as a variant of malignant fibrous histiocytoma." | 1.46 | A rare presentation of myxofibrosarcoma as a Pancoast tumor: a case report. ( Abboud, A; Chedrawy, EG; Hussain, Z; Jevremovic, V; Yousuf, A, 2017) |
| "The role of chemotherapy (CHX) in squamous cell carcinoma of the head and neck (SCCHN) has been expanding." | 1.38 | The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent. ( Ekblad, L; Kjellén, E; Mineta, H; Sasaki, Y; Wahlberg, P; Wennerberg, J, 2012) |
| "Although rapid disease progression had resolved transiently, after the start of high-dose chemotherapy, re-progression was apparently observed from day 14." | 1.32 | Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation. ( Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K, 2003) |
| "Human-derived head-and-neck squamous cell carcinoma xenografts (implanted in nude mice/nine groups of 10 mice) were treated with various treatment modalities and combinations of them (radiation with 5 x 2 or 10 x 2 Gy, hyperthermia at 41 degrees C or 41." | 1.31 | Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival. ( Feyerabend, T; Ressel, A; Weiss, C, 2001) |
| "43 patients with Stage IV squamous cell carcinoma of the head and neck have been treated neoadjuvantly with two cycles chemotherapy (ifosfamide 1." | 1.31 | [The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer]. ( Christoph, B; Esser, E; Hartlapp, J; Hermann, RM; Krech, R; Müller, MK; Wagner, W, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.00) | 18.7374 |
| 1990's | 24 (40.00) | 18.2507 |
| 2000's | 27 (45.00) | 29.6817 |
| 2010's | 6 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, WJ | 1 |
| Zhang, JJ | 1 |
| An, N | 1 |
| Shen, M | 1 |
| Huang, ZX | 1 |
| Li, X | 1 |
| Lopes, LF | 1 |
| Macedo, CR | 1 |
| Aguiar, Sdos S | 1 |
| Barreto, JH | 1 |
| Martins, GE | 1 |
| Sonaglio, V | 1 |
| Milone, M | 1 |
| Lima, ER | 1 |
| Almeida, MT | 1 |
| Lopes, PM | 1 |
| Watanabe, FM | 1 |
| D'Andrea, ML | 1 |
| Pianovski, MA | 1 |
| Melaragno, R | 1 |
| Vianna, SM | 1 |
| Moreira, ME | 1 |
| Bruniera, P | 1 |
| de Oliveira, CZ | 1 |
| Jevremovic, V | 1 |
| Yousuf, A | 1 |
| Hussain, Z | 1 |
| Abboud, A | 1 |
| Chedrawy, EG | 1 |
| Rivera, F | 1 |
| Eugenia Vega-Villegas, M | 1 |
| López, C | 1 |
| Francisca López-Brea, M | 1 |
| Rubio, A | 1 |
| Del Valle, A | 1 |
| García-Reija, F | 1 |
| García-Montesinos, B | 1 |
| Rodríguez-Iglesias, J | 1 |
| Hinojo, C | 1 |
| Márquez, R | 1 |
| Angel Alonso-Bermejo, M | 1 |
| Salcedo, M | 1 |
| Blanco, Y | 1 |
| Vega, N | 1 |
| López-Tarruella, S | 1 |
| Sanz-Ortiz, J | 1 |
| Saba, NF | 1 |
| Choi, M | 1 |
| Muller, S | 1 |
| Shin, HJ | 1 |
| Tighiouart, M | 1 |
| Papadimitrakopoulou, VA | 1 |
| El-Naggar, AK | 1 |
| Khuri, FR | 7 |
| Chen, ZG | 1 |
| Shin, DM | 8 |
| Govender, PS | 1 |
| Specenier, PM | 1 |
| Van Den Brande, J | 1 |
| Schrijvers, D | 1 |
| Huizing, MT | 1 |
| Altintas, S | 1 |
| Dyck, J | 1 |
| Van Den Weyngaert, D | 1 |
| Van Laer, C | 1 |
| Vermorken, JB | 1 |
| Rathore, R | 1 |
| Birnbaum, A | 1 |
| Rathore, B | 1 |
| DiPetrillo, T | 1 |
| Kennedy, T | 1 |
| Ready, N | 1 |
| Huang, YC | 1 |
| Chang, PM | 1 |
| Chen, MH | 1 |
| Chu, PY | 1 |
| Tzeng, CH | 1 |
| Chang, SY | 1 |
| Yang, MH | 1 |
| Sasaki, Y | 1 |
| Kjellén, E | 1 |
| Ekblad, L | 1 |
| Wahlberg, P | 1 |
| Mineta, H | 1 |
| Wennerberg, J | 1 |
| Glisson, BS | 6 |
| Lippman, SM | 8 |
| Ginsberg, L | 4 |
| Diaz, E | 1 |
| Papadimitrakopoulou, V | 2 |
| Feng, L | 1 |
| Francisco, M | 1 |
| Garden, A | 1 |
| Kies, MS | 1 |
| Myers, J | 1 |
| Clayman, G | 2 |
| Hong, WK | 8 |
| Rozan, O | 1 |
| Janot, F | 1 |
| Oberlin, O | 2 |
| Schwaab, G | 1 |
| Quintana, E | 2 |
| Tran Ba Huy, P | 1 |
| Georges, B | 1 |
| Luboinski, B | 1 |
| Misawa, A | 1 |
| Hosoi, H | 1 |
| Tsuchiya, K | 1 |
| Iehara, T | 1 |
| Sawada, T | 1 |
| Sugimoto, T | 1 |
| Haddad, R | 1 |
| Posner, M | 1 |
| Chen, C | 1 |
| Shu, HK | 1 |
| Goldwein, JW | 1 |
| Womer, RB | 1 |
| Maity, A | 1 |
| Pai, VR | 2 |
| Mazumdar, AT | 2 |
| Deshmukh, CD | 2 |
| Bakshi, AV | 2 |
| Parikh, DM | 2 |
| Parikh, PM | 2 |
| Mistry, RC | 2 |
| Pathak, KA | 2 |
| Airoldi, M | 1 |
| Cortesina, G | 1 |
| Giordano, C | 1 |
| Pedani, F | 1 |
| Bumma, C | 1 |
| D'Cruz, AK | 1 |
| Rapidis, AD | 1 |
| Gakiopoulou, H | 1 |
| Stavrianos, SD | 1 |
| Vilos, GA | 1 |
| Faratzis, G | 1 |
| Douzinas, EE | 1 |
| Givalos, N | 1 |
| Patsouris, E | 1 |
| Zak, D | 1 |
| Styler, MJ | 1 |
| Rosenbluth, JZ | 1 |
| Brodsky, I | 1 |
| Bagatell, R | 1 |
| Rumcheva, P | 1 |
| London, WB | 1 |
| Cohn, SL | 1 |
| Look, AT | 1 |
| Brodeur, GM | 1 |
| Frantz, C | 1 |
| Joshi, V | 1 |
| Thorner, P | 1 |
| Rao, PV | 1 |
| Castleberry, R | 1 |
| Bowman, LC | 1 |
| Kanat, O | 1 |
| Ozet, A | 1 |
| Ataergin, SA | 1 |
| Arpaci, F | 2 |
| Ozturk, B | 1 |
| Ozturk, M | 1 |
| Komurcu, S | 1 |
| Kuzhan, O | 1 |
| Recchia, F | 2 |
| Candeloro, G | 1 |
| Di Staso, M | 1 |
| Necozione, S | 1 |
| Bisegna, R | 1 |
| Bratta, M | 1 |
| Tombolini, V | 1 |
| Rea, S | 2 |
| Focan, C | 2 |
| Salamon, E | 2 |
| Le Hung, S | 2 |
| Frère, MH | 2 |
| Mbuyamba, P | 2 |
| Claessens, JJ | 2 |
| Bays-Gallaix, R | 1 |
| Demonceau, G | 1 |
| Benner, SE | 2 |
| Huber, MH | 2 |
| Ben-Dayan, D | 1 |
| Mittelman, M | 1 |
| Floru, S | 1 |
| Djaldetti, M | 1 |
| Forastiere, AA | 1 |
| Urba, SG | 1 |
| Bruggers, CS | 1 |
| Friedman, HS | 1 |
| Tien, R | 1 |
| Delong, R | 1 |
| Stewart, DA | 1 |
| Stewart, DJ | 1 |
| Mai, KT | 1 |
| Izquierdo, R | 1 |
| Leinung, M | 1 |
| Martín, M | 1 |
| Diaz-Rubio, E | 1 |
| González Larriba, JL | 1 |
| Casado, A | 1 |
| Sastre, J | 1 |
| López-Vega, JM | 1 |
| Almenarez, J | 1 |
| Dominguez, S | 1 |
| Shirinian, M | 1 |
| Dimery, IW | 1 |
| Dunnington, JS | 1 |
| Scimeca, PG | 1 |
| James-Herry, AG | 1 |
| Black, KS | 1 |
| Kahn, E | 1 |
| Weinblatt, ME | 1 |
| Devriendt, D | 1 |
| Klastersky, J | 1 |
| Lawhorn, K | 2 |
| Sandler, A | 1 |
| Saxman, S | 1 |
| Bandealy, M | 1 |
| Heilman, D | 1 |
| Monaco, F | 1 |
| McClean, J | 1 |
| Arquette, M | 1 |
| Lee, JJ | 2 |
| Gillenwater, AM | 1 |
| Ang, KK | 2 |
| Clayman, GL | 1 |
| Callender, DL | 1 |
| Flamant, F | 1 |
| Rodary, C | 1 |
| Rey, A | 1 |
| Praquin, MT | 1 |
| Sommelet, D | 1 |
| Theobald, S | 1 |
| Brunat-Mentigny, M | 1 |
| Otten, J | 1 |
| Voûte, PA | 2 |
| Habrand, JL | 1 |
| Martelli, H | 1 |
| Barrett, A | 1 |
| Terrier-Lacombe, MJ | 1 |
| Arndt, CA | 1 |
| Nascimento, AG | 1 |
| Schroeder, G | 1 |
| Schomberg, PJ | 1 |
| Neglia, JP | 1 |
| Sencer, SF | 1 |
| Silberman, TL | 1 |
| Moertel, CL | 1 |
| Tillisch, JK | 1 |
| Miser, JS | 1 |
| Sánchez Parra, M | 1 |
| Churruca, C | 1 |
| Paredes, A | 1 |
| Lacasta, A | 1 |
| López de Argumedo, G | 1 |
| Alvárez, I | 1 |
| Abad, T | 1 |
| Egana, L | 1 |
| Guimón, E | 1 |
| Piera, JM | 1 |
| Victoria, L | 1 |
| McCulloch, TM | 1 |
| Callaghan, EJ | 1 |
| Bauman, NM | 1 |
| Baker, KS | 1 |
| Anderson, JR | 1 |
| Link, MP | 1 |
| Grier, HE | 1 |
| Qualman, SJ | 1 |
| Maurer, HM | 1 |
| Breneman, JC | 1 |
| Wiener, ES | 1 |
| Crist, WM | 1 |
| Ressel, A | 1 |
| Weiss, C | 1 |
| Feyerabend, T | 2 |
| Papadimitrakopoulou, VM | 1 |
| Thurnher, D | 1 |
| Kornfehl, J | 1 |
| Burian, M | 1 |
| Gedlicka, C | 1 |
| Selzer, E | 1 |
| Quint, C | 1 |
| Neuchrist, C | 1 |
| Kornek, GV | 1 |
| Sommer, K | 1 |
| Peters, SO | 1 |
| Robins, IH | 1 |
| Raap, M | 1 |
| Wiedemann, GJ | 1 |
| Remmert, S | 1 |
| Sieg, P | 1 |
| Bittner, C | 1 |
| Hermann, RM | 1 |
| Krech, R | 1 |
| Hartlapp, J | 1 |
| Esser, E | 1 |
| Christoph, B | 1 |
| Müller, MK | 1 |
| Wagner, W | 1 |
| Lalli, A | 1 |
| Lombardo, M | 1 |
| De Filippis, S | 1 |
| Saggio, G | 1 |
| Fabbri, F | 1 |
| Rosselli, M | 1 |
| Capomolla, E | 1 |
| De Neve, W | 1 |
| Claus, F | 1 |
| Duthoy, W | 1 |
| De Meerleer, G | 1 |
| De Wagter, C | 1 |
| Panuel, M | 1 |
| Gentet, JC | 1 |
| Scheiner, C | 1 |
| Ternier, F | 1 |
| Bourlière, B | 1 |
| Faure, F | 1 |
| Devred, P | 1 |
| Plantaz, D | 1 |
| Bachelot, C | 1 |
| Dyon, JF | 1 |
| Pasquier, D | 1 |
| Baudain, P | 1 |
| Durand, C | 1 |
| Bost, M | 1 |
| Coene, IJ | 1 |
| Schouwenburg, PF | 1 |
| Marion, J | 1 |
| Burgers, V | 1 |
| Hilgers, FJ | 1 |
| Cervellino, JC | 1 |
| Araujo, CE | 1 |
| Pirisi, C | 1 |
| Francia, A | 1 |
| Cerruti, R | 1 |
| Buesa, JM | 1 |
| Fernández, R | 1 |
| Esteban, E | 1 |
| Estrada, E | 1 |
| Barón, FJ | 1 |
| Palacio, I | 1 |
| Gracia, M | 1 |
| Lacave, AJ | 1 |
| Klesper, B | 1 |
| Hartmann, N | 1 |
| Kim, MJ | 1 |
| Schmelzle, R | 1 |
| Verweij, J | 1 |
| Alexieva-Figusch, J | 1 |
| de Boer, MF | 1 |
| Reichgelt, B | 1 |
| Stoter, G | 1 |
10 reviews available for ifosfamide and Head and Neck Neoplasms
| Article | Year |
|---|---|
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 2003 |
Ifosfamide in the treatment of head and neck cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 2003 |
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Mo | 2005 |
Transverse nail ridgings (Beau's lines) induced by chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexame | 1994 |
Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials | 1995 |
Chemotherapeutic treatment of malignant chordoma in children.
Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chordoma; Dexa | 1996 |
New cytostatic agents for the treatment of head and neck cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopl | 1997 |
Malignant triton tumor of the head and neck: A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Cisplatin; Combined Modality | 1999 |
Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cl | 2000 |
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Gemcitabine; Head and Nec | 2000 |
23 trials available for ifosfamide and Head and Neck Neoplasms
| Article | Year |
|---|---|
Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control | 2009 |
Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Dose-Response R | 2010 |
A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 2011 |
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2002 |
Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: a retrospective analysis of 519 patients: a single institution experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro | 2003 |
Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Head and | 2004 |
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Proto | 2005 |
Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; CD4-CD8 Ratio | 2008 |
Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1995 |
Ifosfamide in advanced epidermoid head and neck cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Hea | 1993 |
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Female; H | 1996 |
Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dr | 1997 |
Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Female; | 1998 |
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carc | 1998 |
Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Di | 1998 |
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; F | 1998 |
Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Fl | 1999 |
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2000 |
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 2001 |
Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Anemia; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2001 |
Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Fe | 2001 |
Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head | 1991 |
Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Evaluation; Head and Ne | 1991 |
27 other studies available for ifosfamide and Head and Neck Neoplasms
| Article | Year |
|---|---|
Clinical analysis of 40 multiple myeloma patients with extramedullary plasmacytoma of the head.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bortezomib; Dexamethasone; Disease Progressio | 2016 |
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Su | 2016 |
A rare presentation of myxofibrosarcoma as a Pancoast tumor: a case report.
Topics: Antineoplastic Agents, Alkylating; Biopsy, Large-Core Needle; Blepharoptosis; Fibrosarcoma; Head and | 2017 |
Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 2008 |
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Case-Control | 2009 |
Atypical presentation of angiosarcoma of the scalp in the setting of human immunodeficiency virus (HIV).
Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Combine | 2009 |
The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Cisplat | 2012 |
[Pediatric rhabdomyosarcoma of the infratemporal fossa].
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2002 |
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cispl | 2003 |
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Clinical Tria | 2003 |
Sarcomas of the head and neck. Results from the treatment of 25 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carc | 2005 |
A case of advanced scalp angiosarcoma successfully treated with combination chemotherapy of adriamycin, cisplatin and ifosfamide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Head and Neck Neoplas | 2006 |
[Efficacy of sequential chemotherapy including vincristine, cisplatin and ifosfamide in the treatment of stage IV head and neck carcinomas and melanomas with visceral involvement. Preliminary results].
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamou | 1984 |
Ifosfamide (with mesna), vincristine and cis-platinum for carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; He | 1983 |
Cerebral atrophy in an infant following treatment with ifosfamide.
Topics: Atrophy; Brain; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Rhabdomyosarcoma, Embry | 1994 |
Active chemotherapy for metastatic stromal cell tumor of the testis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Head and Neck Neop | 1993 |
Hyponatraemia secondary to administration of ifosfamide.
Topics: Aged; Female; Head and Neck Neoplasms; Humans; Hyponatremia; Ifosfamide; Liposarcoma | 1993 |
Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho | 1998 |
Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dise | 2001 |
A preclinical model for experimental chemotherapy of human head and neck cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Carboplatin; | 2001 |
[The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuv | 2001 |
Intensity modulation techniques for improvement of normal tissue tolerance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Head and Neck Neoplasms; Humans; | 2002 |
[Rhabdoid tumor of the neck].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactino | 1992 |
[Parameningeal cervical rhabdomyosarcoma in the neonatal period].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Head and Neck Neoplasms; Human | 1992 |
Rhabdomyosarcoma of the head and neck in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; | 1992 |
[Effect of cytostatic treatment on microsurgery vascular anastomoses].
Topics: Anastomosis, Surgical; Animals; Endothelium, Vascular; Female; Head and Neck Neoplasms; Ifosfamide; | 1990 |
Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Ifosfamide; | 1988 |